Pharmacological inhibition of s100a4 attenuates fibroblast activation and renal fibrosis

HIGHLIGHTS

  • who: Jia Wen et al. from the Division of Nephrology, Department of Medicine, University of Connecticut School of Medicine, Farmington, CT, USA have published the article: Pharmacological Inhibition of S100A4 Attenuates Fibroblast Activation and Renal Fibrosis, in the Journal: Cells 2022, 2762 of /2022/
  • what: This study examined the functional role of S100A4 in regulating TGF-u03b2/Smad3 signaling in fibroblast activation and kidney fibrosis development. In cultured kidney fibroblasts, the authors show that S100A4 functions as a coactivator of TGF-u03b21/Smad3 to promote fibroblast activation. To determine the biological function of S100A4 inhibition . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?